We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Book Reviews |

Treatment of Multiple Sclerosis

Arch Neurol. 2010;67(8):1031. doi:10.1001/archneurol.2010.165.
Text Size: A A A
Published online


Do we really need another book on the treatment of multiple sclerosis (MS)? Hardly another field in neurology is currently moving as fast as the entire field of neuroimmunology, and the treatment of MS in particular. One could argue that especially in fast-moving fields the publication of books is useless, since already the delay between writing, publishing, and distributing will attenuate the topicality of its content. On the other hand, neuroimmunology is not only a fast-moving field but its current development is also diverse and encompasses many new directions, therapeutic targets, and agents. For the clinical neurologist, even with a special interest in neuroimmunological disorders, it becomes increasingly difficult to keep track, with more than 300 ongoing clinical trials in MS and its related disorders. Hence, the final answer to whether we really need another book on the treatment of MS is a clear yes, as long as the book has comprehensive information on current therapeutic concepts, ongoing developments and changes in these current concepts, and new approaches neurologists will be exposed to in the very near future.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...